• About Us
  • Services
  • Process
  • News
  • Contact
BioPortUSA
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Commercialization
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Commercialization
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
20 Apr

Teicos Pharma hires BioPortUSA

Finish based Teicos Pharma hires BioPortUSA to help with Business Development in the USA

Teicos Pharma is a Finish based Pharmaceutical Start-Up whose business is the production and sales of a new class of inhalable API (active pharmaceutical ingredient) powders for dry powder Inhalers (DPI). According to Mark Lesselroth, the CEO of BioPort “the technology that Dr. David Brown, CEO and Founder of Teicos and his team have developed is truly remarkable. It has the potential to change how patients suffering from diseases that impact the lungs lung  including COPD, Asthma and Cystic Fibrosis by providing them more of the drug they need with less side effect” The company has developed a novel dry particle formulation that enable for better absorption of a drug.

Dr. Brown has also invented a unique device for the transmission of this powder formulation. BioPortUSA has been hired to help identify licensing partners in the U.S.A. who see the value in integrating this drug delivery technology with their products.

Teicos Pharma Oy is a leading provider of manufacturing solutions for carrier-free inhalable API powders used in dry powder inhalers. 

  • Facebook
  • Twitter
  • LinkedIn
  • Print
  • Email

Social Media

  • Twitter
  • LinkedIn
Latest Articles
Medical Device Academy and FDA Attorney join BioPortUSA
Dec 16, 2019, 12:08 PM
#
Swiss Start-Up engages BioPortUSA on help with Reimbursement
Oct 28, 2021, 11:44 AM
Myth vs Reality for Life Sciences Companies Entering the US Market
Oct 22, 2021, 1:29 PM

About BioPortUSA   

BioPort USA

The Gateway For Life Sciences Into The United States

Contact

United States

Mark Lesselroth, CEO

mark(at)bioportusa.com

+1 315 569 0642

©2017—2025 BioPortUSA All rights reserved.

About Us   Services    Process    Contact    Privacy